Pedal power: could a bike ride supercharge Cancer-Fighting cells?
NCT ID NCT06643221
First seen Jun 19, 2026 · Last updated Jun 22, 2026 · Updated 1 time
Summary
This early-stage study explores whether exercise can improve the quality of immune cells collected from healthy donors for blood cancer treatments. Researchers will have healthy volunteers cycle, take a beta blocker or placebo, or receive a drug that mimics adrenaline, then analyze their blood cells in the lab and in mice. The goal is to see if exercise-induced changes make cell therapies more effective and reduce harmful side effects like graft-versus-host disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEUKEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The University of Arizona
RECRUITINGTucson, Arizona, 85719, United States
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
exercise and isoproterenol
What this could lead to
If successful, this could point toward a simple way to collect better immune cells from donors, potentially making cell therapies for blood cancer more effective and reducing side effects like graft-versus-host disease.
What could go wrong
This is a very early, small study in healthy volunteers, not patients. It only tests lab and animal effects, so it may not translate to real patient benefits. The drug isoproterenol can cause heart-related side effects.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.